-The Telegraph The curbs will stall the supply of syringes to international agencies and countries dependent on Indian-made devices The Centre has imposed temporary export restrictions on syringes for Covid-19 vaccines to address a possible shortage that industry executives say could have been averted through government planning they had first requested over 18 months ago. The Union health ministry on Saturday announced restrictions on the export of a range of auto-disposable, disposable and...
More »SEARCH RESULT
Biden undecided on COVID-related TRIPS waiver, as Republican lawmakers oppose India's proposal at WTO -Sriram Lakshman
-The Hindu 12 Republican lawmakers write a seven-page letter to U.S. Trade Representative Katherine Tai on the issue U.S. President Joe Biden said on Tuesday that he had not made a decision on whether the U.S. would support an Indian and South African initiative at the World Trade Organisation (WTO) to waive Trade Related Intellectual Property Rights (TRIPS) to facilitate the production of COVID-19 related vaccines and therapeutics around the world. “Well, we’re...
More »Syringe prices may fall by half or more in January 2018 -Rema Nagarajan
-The Times of India NEW DELHI: The All India syringes and Needles Manufacturers Association has issued a circular to its members to print the maximum retail price (MRP) on the basis of a maximum of 75% margin from December 24, which is observed as Consumer Day, and to implement this latest by January 26 next year. It also wrote to all foreign manufacturers of syringes, urging them to join the effort to...
More »Dengue death: Fortis kept profit margin as high as 1,737 per cent, finds NPPA -Abantika Ghosh
-The Indian Express Aadya died of dengue at the hospital in September, and her family was charged almost Rs 16 lakh for a 15-day stay. New Delhi: Fortis Hospital, Gurgaon made a 1,737 per cent profit on drugs and other consumables that it billed the family of seven-year-old Aadya Singh, the drug pricing regulator has found in an analysis. Aadya died of dengue at the hospital in September, and her family was charged...
More »Max Super Specialty made excessive profits on disposable syringes: CCI
-The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20. CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell...
More »